|
1
|
Khorana AA, Francis CW, Culakova E,
Kuderer NM and Lyman GH: Thromboembolism is a leading cause of
death in cancer patients receiving outpatient chemotherapy. J
Thromb Haemost. 5:632–634. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Falanga A and Russo L: Epidemiology, risk
and outcomes of venous thromboembolism in cancer. Hamostaseologie.
32:115–125. 2012. View
Article : Google Scholar
|
|
3
|
Trousseau A: Phlegmasia Alba Dolens.
Clinique Medicale de l'Hotel-dieu de Paris. 3. JB Balliere et Fils;
Paris: pp. 654–712. 1865
|
|
4
|
Sørensen HT, Mellemkjaer L, Olsen JH and
Baron JA: Prognosis of cancers associated with venous
thromboembolism. N Engl J Med. 343:1846–1850. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Riewald M and Ruf W: Mechanistic coupling
of protease signaling and initiation of coagulation by tissue
factor. Proc Natl Acad Sci USA. 98:7742–7747. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aharon A and Brenner B: Microparticles,
thrombosis and cancer. Best Pract Res Clin Haematol. 22:61–69.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Del Conde I, Bharwani LD, Dietzen DJ,
Pendurthi U, Thiagarajan P and López JA: Microvesicle-associated
tissue factor and Trousseau's syndrome. J Thromb Haemost. 5:70–74.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tilley RE, Holscher T, Belani R, Nieva J
and Mackman N: Tissue factor activity is increased in a combined
platelet and microparticle sample from cancer patients. Thromb Res.
122:604–609. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zwicker JI: Predictive value of tissue
factor bearing microparticles in cancer associated thrombosis.
Thromb Res. 125(Suppl 2): S89–S91. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Castellana D, Toti F and Freyssinet JM:
Membrane microvesicles: Macromessengers in cancer disease and
progression. Thromb Res. 125(Suppl 2): S84–S88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Falanga A: Thrombophilia in cancer. Semin
Thromb Hemost. 31:104–110. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kakkar AK, Lemoine NR, Scully MF, Tebbutt
S and Williamson RC: Tissue factor expression correlates with
histological grade in human pancreatic cancer. Br J Surg.
82:1101–1104. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ueno T, Toi M, Koike M, Nakamura S and
Tominaga T: Tissue factor expression in breast cancer tissues: Its
correlation with prognosis and plasma concentration. Br J Cancer.
83:164–170. 2000.PubMed/NCBI
|
|
14
|
Vrana JA, Stang MT, Grande JP and Getz MJ:
Expression of tissue factor in tumor stroma correlates with
progression to invasive human breast cancer: Paracrine regulation
by carcinoma cell-derived members of the transforming growth factor
beta family. Cancer Res. 56:5063–5070. 1996.PubMed/NCBI
|
|
15
|
Gerotziafas GT, Galea V, Mbemba E,
Khaterchi A, Sassi M, Baccouche H, Prengel C, van Dreden P, Hatmi
M, Bernaudin JF, et al: Tissue factor over-expression by human
pancreatic cancer cells BXPC3 is related to higher prothrombotic
potential as compared to breast cancer cells MCF7. Thromb Res.
129:779–786. 2012. View Article : Google Scholar
|
|
16
|
Thomas GM, Panicot-Dubois L, Lacroix R,
Dignat-George F, Lombardo D and Dubois C: Cancer cell-derived
microparticles bearing P-selectin glycoprotein ligand 1 accelerate
thrombus formation in vivo. J Exp Med. 206:1913–1927. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gheldof D, Mullier F, Bailly N, Devalet B,
Dogné JM, Chatelain B and Chatelain C: Microparticle bearing tissue
factor: A link between promyelocytic cells and hypercoagulable
state. Thromb Res. 133:433–439. 2014. View Article : Google Scholar
|
|
18
|
Lacroix R and Dignat-George F:
Microparticles as a circulating source of procoagulant and
fibrinolytic activities in the circulation. Thromb Res. 129(Suppl
2): S27–S29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hron G, Kollars M, Weber H, Sagaster V,
Quehenberger P, Eichinger S, Kyrle PA and Weltermann A: Tissue
factor-positive microparticles: Cellular origin and association
with coagulation activation in patients with colorectal cancer.
Thromb Haemost. 97:119–123. 2007.PubMed/NCBI
|
|
20
|
Tesselaar ME, Romijn FP, Van Der Linden
IK, Prins FA, Bertina RM and Osanto S: Microparticle-associated
tissue factor activity: A link between cancer and thrombosis? J
Thromb Haemost. 5:520–527. 2007. View Article : Google Scholar
|
|
21
|
Wang JG, Geddings JE, Aleman MM, Cardenas
JC, Chantrathammachart P, Williams JC, Kirchhofer D, Bogdanov VY,
Bach RR, Rak J, et al: Tumor-derived tissue factor activates
coagulation and enhances thrombosis in a mouse xenograft model of
human pancreatic cancer. Blood. 119:5543–5552. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Van Dreden P, Rousseau A, Savoure A,
Lenormand B, Fontaine S and Vasse M: Plasma thrombomodulin
activity, tissue factor activity and high levels of circulating
procoagulant phospholipid as prognostic factors for acute
myocardial infarction. Blood Coagul Fibrinolysis. 20:635–641. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rousseau A, Favier R and Van Dreden P:
Elevated circulating soluble thrombomodulin activity, tissue factor
activity and circulating procoagulant phospholipids: New and useful
markers for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol.
146:46–49. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schneider P, Van Dreden P, Rousseau A,
Kassim Y, Legrand E, Vannier JP and Vasse M: Increased levels of
tissue factor activity and procoagulant phospholipids during
treatment of children with acute lymphoblastic leukaemia. Br J
Haematol. 148:582–592. 2010. View Article : Google Scholar
|
|
25
|
Gerotziafas GT, Depasse F, Busson J,
Leflem L, Elalamy I and Samama MM: Towards a standardization of
thrombin generation assessment: The influence of tissue factor,
platelets and phospholipids concentration on the normal values of
Thrombogram-Thrombinoscope assay. Thromb J. 3:162005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lacroix R, Judicone C, Poncelet P, Robert
S, Arnaud L, Sampol J and Dignat-George F: Impact of pre-analytical
parameters on the measurement of circulating microparticles:
Towards standardization of protocol. J Thromb Haemost. 10:437–446.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bouvy C, Gheldof D, Chatelain C, Mullier F
and Dogné JM: Contributing role of extracellular vesicles on
vascular endothelium haemostatic balance in cancer. J Extracell
Vesicles. 3:102014.
|
|
28
|
Key NS, Chantrathammachart P, Moody PW and
Chang JY: Membrane microparticles in VTE and cancer. Thromb Res.
125(Suppl 2): S80–S83. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chew HK, Wun T, Harvey D, Zhou H and White
RH: Incidence of venous thromboembolism and its effect on survival
among patients with common cancers. Arch Intern Med. 166:458–464.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Prandoni P, Falanga A and Piccioli A:
Cancer and venous thromboembolism. Lancet Oncol. 6:401–410. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thaler J, Ay C, Mackman N, Metz-Schimmerl
S, Stift J, Kaider A, Müllauer L, Gnant M, Scheithauer W and
Pabinger I: Microparticle-associated tissue factor activity in
patients with pancreatic cancer: Correlation with
clinicopathological features. Eur J Clin Invest. 43:277–285. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thaler J, Koder S, Kornek G, Pabinger I
and Ay C: Microparticleassociated tissue factor activity in
patients with metastatic pancreatic cancer and its effect on fibrin
clot formation. Transl Res. 163:145–150. 2014. View Article : Google Scholar
|
|
33
|
Rousseau A, Van Dreden P, Larsen A, Sabbah
M, Elalamy I and Gerotziafas GT: Differential contribution of
tissue factor and Factor XII to thrombin generation triggered by
breast and pancreatic cancer cells. Int J Oncol. In press.
|
|
34
|
Castellana D, Kunzelmann C and Freyssinet
JM: Pathophysiologic significance of procoagulant microvesicles in
cancer disease and progression. Hamostaseologie. 29:51–57.
2009.PubMed/NCBI
|
|
35
|
Yu JL and Rak JW: Shedding of tissue
factor (TF)-containing microparticles rather than alternatively
spliced TF is the main source of TF activity released from human
cancer cells. J Thromb Haemost. 2:2065–2067. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Geddings JE, Hisada Y, Boulaftali Y, Getz
TM, Whelihan M, Fuentes R, Dee R, Cooley BC, Key NS, Wolberg AS, et
al: Tissue factor-positive tumor microvesicles activate platelets
and enhance thrombosis in mice. J Thromb Haemost. 14:153–166. 2016.
View Article : Google Scholar :
|
|
37
|
Falanga A, Panova-Noeva M and Russo L:
Procoagulant mechanisms in tumour cells. Best Pract Res Clin
Haematol. 22:49–60. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zwicker JI, Liebman HA, Neuberg D, Lacroix
R, Bauer KA, Furie BC and Furie B: Tumor-derived tissue
factor-bearing microparticles are associated with venous
thromboembolic events in malignancy. Clin Cancer Res. 15:6830–6840.
2009. View Article : Google Scholar : PubMed/NCBI
|
